163 related articles for article (PubMed ID: 11675420)
1. Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells.
Witowski J; Wisniewska J; Korybalska K; Bender TO; Breborowicz A; Gahl GM; Frei U; Passlick-Deetjen J; Jörres A
J Am Soc Nephrol; 2001 Nov; 12(11):2434-2441. PubMed ID: 11675420
[TBL] [Abstract][Full Text] [Related]
2. Effect of glucose degradation products on human peritoneal mesothelial cell function.
Witowski J; Korybalska K; Wisniewska J; Breborowicz A; Gahl GM; Frei U; Passlick-Deetjen J; Jörres A
J Am Soc Nephrol; 2000 Apr; 11(4):729-739. PubMed ID: 10752532
[TBL] [Abstract][Full Text] [Related]
3. Glucose degradation products and peritoneal membrane function.
Witowski J; Bender TO; Gahl GM; Frei U; Jörres A
Perit Dial Int; 2001; 21(2):201-5. PubMed ID: 11330569
[TBL] [Abstract][Full Text] [Related]
4. Glucose degradation products (GDP) retard remesothelialization independently of D-glucose concentration.
Morgan LW; Wieslander A; Davies M; Horiuchi T; Ohta Y; Beavis MJ; Craig KJ; Williams JD; Topley N
Kidney Int; 2003 Nov; 64(5):1854-66. PubMed ID: 14531821
[TBL] [Abstract][Full Text] [Related]
5. L-2-oxothiazolidine-4-carboxylic acid reduces in vitro cytotoxicity of glucose degradation products.
Breborowicz A; Witowski J; Polubinska A; Pyda M; Oreopoulos D
Nephrol Dial Transplant; 2004 Dec; 19(12):3005-11. PubMed ID: 15507476
[TBL] [Abstract][Full Text] [Related]
6. Mesothelial toxicity of peritoneal dialysis fluids is related primarily to glucose degradation products, not to glucose per se.
Witowski J; Bender TO; Wisniewska-Elnur J; Ksiazek K; Passlick-Deetjen J; Breborowicz A; Jörres A
Perit Dial Int; 2003; 23(4):381-90. PubMed ID: 12968847
[TBL] [Abstract][Full Text] [Related]
7. Comparison of icodextrin- and glucose-based peritoneal dialysis fluids in their acute and chronic effects on human peritoneal mesothelial cells.
Bender TO; Witowski J; Ksiazek K; Jörres A
Int J Artif Organs; 2007 Dec; 30(12):1075-82. PubMed ID: 18203069
[TBL] [Abstract][Full Text] [Related]
8. Time to reconsider saline as the ideal rinsing solution during abdominal surgery.
Połubinska A; Winckiewicz M; Staniszewski R; Breborowicz A; Oreopoulos DG
Am J Surg; 2006 Sep; 192(3):281-5. PubMed ID: 16920418
[TBL] [Abstract][Full Text] [Related]
9. Regulation of CCN2/CTGF and related cytokines in cultured peritoneal cells under conditions simulating peritoneal dialysis.
Leung JC; Chan LY; Tam KY; Tang SC; Lam MF; Cheng AS; Chu KM; Lai KN
Nephrol Dial Transplant; 2009 Feb; 24(2):458-69. PubMed ID: 18805993
[TBL] [Abstract][Full Text] [Related]
10. Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells.
Ha H; Cha MK; Choi HN; Lee HB
Perit Dial Int; 2002; 22(2):171-7. PubMed ID: 11990400
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of receptors for advanced glycation end-products in peritoneal mesothelial cells exposed to glucose degradation products.
Lai KN; Leung JC; Chan LY; Li FF; Tang SC; Lam MF; Tse KC; Yip TP; Chan TM; Wieslander A; Vlassara H
Clin Exp Immunol; 2004 Dec; 138(3):466-75. PubMed ID: 15544624
[TBL] [Abstract][Full Text] [Related]
12. The role of the glyoxalase pathway in reducing mesothelial toxicity of glucose degradation products.
Korybalska K; Wisniewska-Elnur J; Trómińska J; Jörres A; Breborowicz A; Witowski J
Perit Dial Int; 2006; 26(2):259-65. PubMed ID: 16623434
[TBL] [Abstract][Full Text] [Related]
13. Glucose degradation products in peritoneal dialysis fluids: do they harm?
Witowski J; Jörres A; Korybalska K; Ksiazek K; Wisniewska-Elnur J; Bender TO; Passlick-Deetjen J; Breborowicz A
Kidney Int Suppl; 2003 May; (84):S148-51. PubMed ID: 12694333
[TBL] [Abstract][Full Text] [Related]
14. Glucose degradation products downregulate ZO-1 expression in human peritoneal mesothelial cells: the role of VEGF.
Leung JC; Chan LY; Li FF; Tang SC; Chan KW; Chan TM; Lam MF; Wieslander A; Lai KN
Nephrol Dial Transplant; 2005 Jul; 20(7):1336-49. PubMed ID: 15814533
[TBL] [Abstract][Full Text] [Related]
15. Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis.
Witowski J; Topley N; Jörres A; Liberek T; Coles GA; Williams JD
Kidney Int; 1995 Jan; 47(1):282-93. PubMed ID: 7731159
[TBL] [Abstract][Full Text] [Related]
16. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
[TBL] [Abstract][Full Text] [Related]
17. Emodin ameliorates glucose-induced matrix synthesis in human peritoneal mesothelial cells.
Chan TM; Leung JK; Tsang RC; Liu ZH; Li LS; Yung S
Kidney Int; 2003 Aug; 64(2):519-33. PubMed ID: 12846747
[TBL] [Abstract][Full Text] [Related]
18. Increased survival of mesothelial cells from the peritoneum in peritoneal dialysis fluid.
Lai KN; Ho SK; Leung J; Tang SC; Chan TM; Li FK
Cell Biol Int; 2001; 25(5):445-50. PubMed ID: 11401332
[TBL] [Abstract][Full Text] [Related]
19. Impact of low glucose degradation product bicarbonate/lactate-buffered dialysis solution on the epithelial-mesenchymal transition of peritoneum.
Oh EJ; Ryu HM; Choi SY; Yook JM; Kim CD; Park SH; Chung HY; Kim IS; Yu MA; Kang DH; Kim YL
Am J Nephrol; 2010; 31(1):58-67. PubMed ID: 19887789
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells.
Witowski J; Korybalska K; Ksiazek K; Wisniewska-Elnur J; Jörres A; Lage C; Schaub TP; Passlick-Deetjen J; Breborowicz A; Grzegorzewska A; Ksiazek A; Liberek T; Lichodziejewska-Niemierko M; Majdan M; Rutkowski B; Stompór T; Sulowicz W
Nephrol Dial Transplant; 2004 Apr; 19(4):917-24. PubMed ID: 15031350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
